Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2
Key facts
- Who runs it
- Mikhail N Koffarnus
- Where
- Lexington and Roanoke, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 91 people enrolled
- Started
- 15 Jul 2019
- Ended
- 31 Aug 2026
- Type of study
- Interventional, 5 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Contingency Management
- Record updated
- 8 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- Recently completed or currently completing an alcohol detoxification program through the Carilion Clinic or University of Kentucky Healthcare system
- Meet DSM-V criteria for alcohol use disorder
- Abstinent from alcohol at the time of consent
Who cannot take part
- Alcohol use disorder is secondary to another substance use disorder
Where in United States
- University of Kentucky HealthCareLexington, United States
- Virginia Tech CarilionRoanoke, United States
About the trial
What the trial wants to find out
Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. As our feasibility study demonstrates, remote breathalyzer monitoring drastically improves the practicality of delivering an alcohol contingency management intervention. In Experiment 2, we will test whether the addition of remote abstinence incentives to treatment as usual improves outpatient treatment outcomes and prevents relapse following inpatient detoxification at a regional hospital system. We will also assess whether readmission rates are reduced using a newly developed smartphone app and breathalyzer.
The 5 groups in the trial
- Active Comparator: Group A (Intensive incentives)Existing treatment, for comparison
Group A will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will also have the opportunity to earn more incentives for providing negative results. For the first 3 weeks, these additional incentives will scale based on the number of consecutive days of sustained negative samples. For the remaining weeks incentives will be based on a randomized "prize" drawing.
Treatment: Contingency Management
- Active Comparator: Group B (Prize-based incentives)Existing treatment, for comparison
Group B will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will only have the opportunity to earn more incentives based on a randomized "prize" drawing if they submit a negative sample.
Treatment: Contingency Management
- Sham Comparator: Group C (Intensive incentives)Sham treatment, for comparison
Group C serves as a direct control group to Group A and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.
Treatment: Contingency management
- Sham Comparator: Group D (Price-based incentives)Sham treatment, for comparison
Group D serves as a direct control group to Group B and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.
Treatment: Contingency management
- No Intervention: Group E (no incentives)No study treatment, for comparison
Group E will have no monitoring intervention, they will only complete assessment sessions.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement With an Underserved Population
- Record updated
- 8 October 2026